Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - olanzapine, quantity: 5 mg - tablet, orally disintegrating - excipient ingredients: microcrystalline cellulose; polacrilin potassium; aspartame; mannitol; crospovidone; sodium stearylfumarate; colloidal anhydrous silica; flavour - zylapine odt is indicated for the treatment of schizophrenia and related psychoses. zylapine odt alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. zylapine odt for preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern xp ip pty ltd - lorazepam, quantity: 2.5 mg - tablet - excipient ingredients: maize starch; microcrystalline cellulose; sodium starch glycollate type a; magnesium stearate; polacrilin potassium; lactose monohydrate; povidone; crospovidone - management of anxiety disorders or for the short-term relief of the symptoms of anxiety or anxiety associated with depressive symptoms. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. the physician should periodically reassess the usefulness of the drug for the individual patient. pre-surgical medication taken the night before surgery and/or 1-2 hours prior to the surgical procedure.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern xp ip pty ltd - lorazepam, quantity: 1 mg - tablet - excipient ingredients: maize starch; microcrystalline cellulose; sodium starch glycollate type a; magnesium stearate; polacrilin potassium; lactose monohydrate; povidone; crospovidone - management of anxiety disorders or for the short-term relief of the symptoms of anxiety or anxiety associated with depressive symptoms. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. the physician should periodically reassess the usefulness of the drug for the individual patient. pre-surgical medication taken the night before surgery and/or 1-2 hours prior to the surgical procedure.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern xp ip pty ltd - lorazepam, quantity: 2.5 mg - tablet - excipient ingredients: maize starch; microcrystalline cellulose; sodium starch glycollate type a; magnesium stearate; polacrilin potassium; lactose monohydrate; povidone; crospovidone - management of anxiety disorders or for the short-term relief of the symptoms of anxiety or anxiety associated with depressive symptoms. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. the physician should periodically reassess the usefulness of the drug for the individual patient. pre-surgical medication taken the night before surgery and/or 1-2 hours prior to the surgical procedure.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern xp ip pty ltd - lorazepam, quantity: 1 mg - tablet - excipient ingredients: maize starch; microcrystalline cellulose; sodium starch glycollate type a; magnesium stearate; polacrilin potassium; lactose monohydrate; povidone; crospovidone - management of anxiety disorders or for the short-term relief of the symptoms of anxiety or anxiety associated with depressive symptoms. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. the physician should periodically reassess the usefulness of the drug for the individual patient. pre-surgical medication taken the night before surgery and/or 1-2 hours prior to the surgical procedure.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern xp ip pty ltd - lorazepam, quantity: 0.5 mg - tablet - excipient ingredients: maize starch; microcrystalline cellulose; sodium starch glycollate type a; magnesium stearate; polacrilin potassium; lactose monohydrate; povidone; crospovidone - management of anxiety disorders or for the short-term relief of the symptoms of anxiety or anxiety associated with depressive symptoms. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. the physician should periodically reassess the usefulness of the drug for the individual patient. pre-surgical medication taken the night before surgery and/or 1-2 hours prior to the surgical procedure.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - perindopril erbumine, quantity: 8 mg - tablet - excipient ingredients: silicon dioxide; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; polacrilin potassium; hydroxypropylbetadex - treatment of hypertension. treatment of heart failure. in such patients it is recommended that perindopril sandoz be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril have not been demonstrated for new york heart association category iv patients). patients with established coronary artery disease (see section 5.1 pharmacodynamic properties), who are stable on concomitant therapy and have no heart failure, to reduce the risk of nonfatal myocardial infarction or cardiac arrest.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - perindopril erbumine, quantity: 4 mg - tablet - excipient ingredients: colloidal anhydrous silica; magnesium stearate; silicon dioxide; polacrilin potassium; hydroxypropylbetadex; microcrystalline cellulose - treatment of hypertension. treatment of heart failure. in such patients it is recommended that perindopril sandoz be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril have not been demonstrated for new york heart association category iv patients). patients with established coronary artery disease (see section 5.1 pharmacodynamic properties), who are stable on concomitant therapy and have no heart failure, to reduce the risk of nonfatal myocardial infarction or cardiac arrest.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - perindopril erbumine, quantity: 2 mg - tablet - excipient ingredients: magnesium stearate; microcrystalline cellulose; polacrilin potassium; silicon dioxide; hydroxypropylbetadex; colloidal anhydrous silica - treatment of hypertension. treatment of heart failure. in such patients it is recommended that perindopril sandoz be given with a diuretic and/or digoxin under close medical supervision. (the safety and efficacy of perindopril have not been demonstrated for new york heart association category iv patients). patients with established coronary artery disease (see see section 5.1 pharmacodynamic properties), who are stable on concomitant therapy and have no heart failure, to reduce the risk of nonfatal myocardial infarction or cardiac arrest.

Australia - English - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - lamotrigine, quantity: 50 mg - tablet, dispersible - excipient ingredients: magnesium stearate; magnesium carbonate hydrate; microcrystalline cellulose; povidone; sucralose; polacrilin potassium; flavour - lamotrigine is an antiepileptic drug for the treatment of partial and generalised seizures in adults and children.,there is extensive experience with lamotrigine used initially as ?add-on? therapy. the use of lamotrigine has also been found to be effective as monotherapy following withdrawal of concomitant antiepileptic drugs.,initial monotherapy treatment in newly diagnosed paediatric patients is not recommended.